STAT60%
Shortlist for new FDA commissioner now in hands of White House 28%
By Daniel Payne24%
7/8/2026, 11:51:54 AM
BS Summary: This article contains 11 faulty reasoning types, including Negativity Bias, Unattributed Quote, and Framing Effect, with Attempt to Sell a Product or Service as the most egregious example at 45.1% saturation with 125 hits. Analysis detected 357 faulty-reasoning hits from 277 analyzed words, generating a BS Score of 33% and a BS Rank of 28% (20,069 of 27,848 articles). This article is better (less manipulative) than 72.10% of the article peer group.
White House reviewing top contenders to lead FDA
Heidi Overton, Jeffrey Vacirca, and Stephen Ferrara are among finalists
Sarah Silbiger/Getty Images
Washington Correspondent
Daniel covers the intersection of the health industry and the federal government.
He reports on corporate influence in government, the health consequences of federal policies, and the politics of health care.
Confidential tips can be sent on Signal at danielp.100.
WASHINGTON — The top contenders to lead the Food and Drug Administration have been sent to the White House for a final review and decision, according to a person familiar with the process.
The finalists include Heidi Overton, a White House adviser; Jeffrey Vacirca, an oncologist and health system executive; and Stephen Ferrara, a health affairs official at the Defense Department.
STAT+ Exclusive Story
Already have an account?
Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.
Totals $468 per year
for 3 months, then $399/year
Savings start at 25%!
$300 Annually per user
To read the rest of this story subscribe to STAT+.
FDA , HHS , Pharmaceuticals , Policy , STAT+ , White House
Submit a correction request Reprints
STAT Plus: In private meeting, Trump officials push to onshore generic drugmaking
STAT Plus: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms
STAT Plus: Medicare takes another swing at 340B cuts to hospitals
STAT Plus: Elevance sues government over $115 million tied to Medicare Advantage star ratings
STAT Plus: Anthropic releases Claude Science, a product aimed at researchers, the pharma industry
Speakers
2speakers52%attributed speech132writer words
Selected voice
91%flagged-word coverageorganization:STAT+
137 attributed words94% of attributed speech61% writer coverage
Attribution is sentence-level. Pattern percentages are calculated only from words assigned to that voice.
Loading…
Loading…
Loading…
Loading…
Analysis
Hover over highlighted words in the article to view the associated bias or fallacy analysis.